4.8 Article

Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

Fasiha Kanwal et al.

GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals

Stacey B. Prenner et al.

JOURNAL OF HEPATOLOGY (2017)

Editorial Material Gastroenterology & Hepatology

Hepatocellular carcinoma and direct acting antiviral treatments: Controversy after the revolution

Jean-Charles Nault et al.

JOURNAL OF HEPATOLOGY (2016)

Letter Gastroenterology & Hepatology

Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing

Calogero Camma et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis

Graham R. Foster et al.

JOURNAL OF HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

Michelle C. M. Cheung et al.

JOURNAL OF HEPATOLOGY (2016)

Editorial Material Gastroenterology & Hepatology

LIVER CANCER Effect of HCV clearance with direct-acting antiviral agents on HCC

Josep M. Llovet et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)

Article Cardiac & Cardiovascular Systems

Propensity Score Methods for Confounding Control in Nonexperimental Research

M. Alan Brookhart et al.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2013)

Article Medicine, General & Internal

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Adriaan J. van der Meer et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Article Gastroenterology & Hepatology

A Sustained Virologic Response Reduces Risk of All-Cause Mortality in Patients With Hepatitis C

Lisa I. Backus et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Review Gastroenterology & Hepatology

Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma

Riccardo Lencioni et al.

SEMINARS IN LIVER DISEASE (2010)